{
    "clinical_study": {
        "@rank": "78947", 
        "arm_group": {
            "arm_group_label": "Cohort 1"
        }, 
        "brief_summary": {
            "textblock": "Evaluate the burden of invasive group B streptococcal (GBS) disease in young infants (up to\n      90 days of age) in China, in terms of incidence, case fatality rate and serotype\n      distribution"
        }, 
        "brief_title": "Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Invasive Group B Streptococcal Disease", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Positive culture for GBS from one or more of the following normally sterile sites:\n             blood, cerebrospinal fluid (CSF), pleural fluid, peritoneal fluid, pericardial fluid,\n             surgical aspirate, bone, joint fluid, suprapubic bladder aspiration or internal body\n             site (e.g., lymph node, brain).\n\n          2. \u226490 days old at the time of GBS confirmation.\n\n          3. Voluntary written informed consent provided.\n\n        Exclusion Criteria:\n\n          -  None."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Days", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Infants (up to and including 90 days of age) born in or treated in a study hospital"
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01933646", 
            "org_study_id": "V98_23OB"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Group B streptococcus", 
            "Incidence", 
            "Case fatality rate", 
            "Serotype distribution"
        ], 
        "lastchanged_date": "May 9, 2014", 
        "link": {
            "description": "Good Epidemiological Practice: 2007", 
            "url": "http://ieaweb.org/2010/04/good-epidemiological-practice-gep/"
        }, 
        "location": {
            "contact": {
                "email": "xiangliuhaiying@aliyun.com", 
                "last_name": "Haiying Liu, Dr"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510623"
                }, 
                "name": "Guangzhou Women and Children's Medical Centre"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China: Incidence, Case Fatality Rate and Serotype Distribution", 
        "overall_contact": {
            "last_name": "Novartis Drug Informaton Services", 
            "phone": "+1 800 244 7668"
        }, 
        "overall_official": {
            "affiliation": "Novartis Vaccines", 
            "last_name": "Novartis Vaccines", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Incidence of group B streptococcal (GBS) disease", 
                "safety_issue": "No", 
                "time_frame": "From birth to 90 days of age"
            }, 
            {
                "measure": "Case Fatality Rate of GBS disease", 
                "safety_issue": "No", 
                "time_frame": "From birth to 90 days of age"
            }, 
            {
                "measure": "GBS serotype distribution", 
                "safety_issue": "No", 
                "time_frame": "From birth to 90 days of age"
            }
        ], 
        "reference": {
            "PMID": "17336588", 
            "citation": "Heath PT, Schuchat A. Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):411-24. Epub 2007 Mar 2. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01933646"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Vaccines", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}